Alan X. Pan

413 total citations
11 papers, 331 citations indexed

About

Alan X. Pan is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Surgery. According to data from OpenAlex, Alan X. Pan has authored 11 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Anesthesiology and Pain Medicine and 2 papers in Surgery. Recurrent topics in Alan X. Pan's work include Treatment of Major Depression (4 papers), Anesthesia and Sedative Agents (3 papers) and Nausea and vomiting management (2 papers). Alan X. Pan is often cited by papers focused on Treatment of Major Depression (4 papers), Anesthesia and Sedative Agents (3 papers) and Nausea and vomiting management (2 papers). Alan X. Pan collaborates with scholars based in Singapore, United States and China. Alan X. Pan's co-authors include Kwee Poo Yeo, Mary Pat Knadler, Stephen D. Wise, Maggie Lim, Celedon Gonzales, Michael Skinner, Shobha Reddy, Korbtham Sathirakul, Noelle Lim and J. L. Chong and has published in prestigious journals such as Journal of Hepatology, Clinical Pharmacology & Therapeutics and Psychoneuroendocrinology.

In The Last Decade

Alan X. Pan

11 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan X. Pan Singapore 9 148 108 98 49 43 11 331
Jocelyne Chabert Switzerland 10 111 0.8× 94 0.9× 110 1.1× 60 1.2× 58 1.3× 13 500
Jill Chappell United States 8 143 1.0× 94 0.9× 87 0.9× 57 1.2× 22 0.5× 13 396
Maggie Lim Singapore 3 116 0.8× 65 0.6× 70 0.7× 32 0.7× 25 0.6× 4 238
Kwee Poo Yeo Singapore 13 153 1.0× 131 1.2× 99 1.0× 65 1.3× 47 1.1× 26 562
L. Bergougnan France 8 117 0.8× 89 0.8× 73 0.7× 19 0.4× 26 0.6× 13 531
Tonya Quinlan United States 12 120 0.8× 183 1.7× 49 0.5× 42 0.9× 45 1.0× 16 387
Yoshitsugu Yanagihara Japan 8 201 1.4× 36 0.3× 70 0.7× 70 1.4× 32 0.7× 15 415
Shobha Reddy United States 10 214 1.4× 117 1.1× 120 1.2× 60 1.2× 54 1.3× 19 636
B Vandel France 13 196 1.3× 164 1.5× 104 1.1× 62 1.3× 63 1.5× 50 519
W. H. Greb United States 10 172 1.2× 124 1.1× 77 0.8× 27 0.6× 30 0.7× 15 401

Countries citing papers authored by Alan X. Pan

Since Specialization
Citations

This map shows the geographic impact of Alan X. Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan X. Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan X. Pan more than expected).

Fields of papers citing papers by Alan X. Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan X. Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan X. Pan. The network helps show where Alan X. Pan may publish in the future.

Co-authorship network of co-authors of Alan X. Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Alan X. Pan. A scholar is included among the top collaborators of Alan X. Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan X. Pan. Alan X. Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Pan, Alan X., Amparo de la Peña, Kwee Poo Yeo, et al.. (2007). Effects of smoking cessation, acute re‐exposure and nicotine replacement in smokers on AIR® inhaled insulin pharmacokinetics and glucodynamics. British Journal of Clinical Pharmacology. 65(4). 480–487. 4 indexed citations
3.
Si, Tianmei, Mary Pat Knadler, Kwee Poo Yeo, et al.. (2007). Pharmacokinetics and Tolerability of??Duloxetine following Oral Administration to Healthy Chinese Subjects. Clinical Pharmacokinetics. 46(9). 767–775. 13 indexed citations
4.
Higgs, Richard E., J Brandt, Michael D. Knierman, et al.. (2007). Identifying Pharmacodynamic Protein Markers of Centrally Active Drugs in Humans:  A Pilot Study in a Novel Clinical Model. Journal of Proteome Research. 6(3). 955–966. 13 indexed citations
5.
Pan, Alan X., Eunice Yuen, Kwee Poo Yeo, et al.. (2007). Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele. British Journal of Clinical Pharmacology. 64(4). 445–449. 34 indexed citations
6.
Yeo, Kwee Poo, et al.. (2006). Duloxetine pharmacokinetics are similar in Japanese and Caucasian subjects. British Journal of Clinical Pharmacology. 63(3). 310–314. 34 indexed citations
7.
Lowe, Stephen L., Kwee Poo Yeo, Danny Soon, et al.. (2005). l-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI. Psychoneuroendocrinology. 31(4). 473–484. 14 indexed citations
8.
Pan, Alan X., et al.. (2004). Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers. British Journal of Clinical Pharmacology. 57(5). 652–656. 23 indexed citations
9.
Skinner, Michael, Alan X. Pan, Korbtham Sathirakul, et al.. (2003). Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers. Clinical Pharmacology & Therapeutics. 73(3). 170–177. 150 indexed citations
10.
Soon, Danny, et al.. (2002). Fatty liver (FL) in chronic hepatitis B carriers may affect the interpretation of alanine aminotransferase (ALT) elevations. Journal of Hepatology. 36. 131–131. 2 indexed citations
11.
Lim, Noelle, et al.. (2001). Single dose diclofenac suppository reduces post-Cesarean PCEA requirements. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 48(4). 383–386. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026